International Stem Cell CORP·4

Nov 8, 1:18 PM ET

Semechkin Andrey 4

4 · International Stem Cell CORP · Filed Nov 8, 2023

Insider Transaction Report

Form 4
Period: 2023-11-06
Semechkin Andrei
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-11-06+500,000500,000 total
    Exercise: $0.12Exp: 2033-11-06Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]3/36th of the shares underlying such options shall vest on 2/06/2024, and the remaining share in equal monthly installments over a period of 33 months.

Documents

1 file
  • 4
    ownership.xmlPrimary